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Abstract
Background: Because large, prospective, population-based data sets describing maternal outcomes are typically
not available in low- and middle-income countries, it is difficult to monitor maternal mortality rates over time and
to identify factors associated with maternal mortality. Early identification of risk factors is essential to develop
comprehensive intervention strategies preventing pregnancy-related complications. Our objective was to describe
maternal mortality rates in a large, multi-country dataset and to determine maternal, pregnancy-related, delivery
and postpartum characteristics that are associated with maternal mortality.
Methods: We collected data describing all pregnancies from 2010 to 2013 among women enrolled in the multi-
national Global Network for Women’s and Children’s Health Research Maternal and Neonatal Health Registry
(MNHR). We reported the proportion of mothers who died per pregnancy and the maternal mortality ratio (MMR).
Generalized linear models were used to evaluate the relationship of potential medical and social factors and
maternal mortality and to develop point and interval estimates of relative risk associated with these factors.
Generalized estimating equations were used to account for the correlation of outcomes within cluster to develop
appropriate confidence intervals.
Results: We recorded 277,736 pregnancies and 402 maternal deaths for an MMR of 153/100,000 live births. We
observed an improvement in the total MMR from 166 in 2010 to 126 in 2013. The MMR in Latin American sites
(91) was lower than the MMR in Asian (178) and African sites (125). When adjusted for study site and the other
variables, no formal education (RR 3.2 [1.5, 6.9]), primary education only (RR 3.4 [1.6, 7.5]), secondary education only
(RR 2.5 [1.1, 5.7]), lack of antenatal care (RR 1.8 [1.2, 2.5]), caesarean section delivery (RR 1.9 [1.3, 2.8]), hemorrhage
(RR 3.3 [2.2, 5.1]), and hypertensive disorders (RR 7.4 [5.2, 10.4]) were associated with higher risks of death.
Conclusions: The MNHR identified preventable causes of maternal mortality in diverse settings in low- and middle-
income countries. The MNHR can be used to monitor public health strategies and determine their association with
reducing maternal mortality.
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Background
More than 99% of the women who die from pregnancy-
related complications live in low- and middle-income
countries where systematic data collection is of variable
quality [1-4]. In these countries, most data sets are incom-
plete or record small numbers of deaths. Because maternal
deaths occur infrequently, it is difficult to draw inferences
about the underlying causes of mortality from these data
sets. In addition to the relatively small numbers of mater-
nal deaths, many reports are limited to women who were
treated in facilities, which might underrepresent mortality
due to deaths that occur at home or outside of a health
care facility. Also, they misclassify maternal death as that
being attributable to causes other than pregnancy-related
causes [5-8]. Because prospective data sets that record
large numbers of maternal deaths are lacking, much of the
information available relative to maternal mortality is
derived from models that generate estimates or synthesize
data from several studies or data repositories [5,9,10].
Therefore, a reliable, comprehensive set of medical and
social factors that are strongly associated with maternal
mortality is needed from prospective population-based
data sets that can also track maternal mortality rates over
time. Early identification of risk factors is essential to
develop comprehensive intervention strategies preventing
pregnancy-related complications. Maternal mortality rates
will not be reduced without comprehensive intervention
strategies that include monitoring of risk factors shown to
be associated with maternal mortality [11,12].
The Eunice Kennedy Shriver National Institute of Child
Health and Human Development (NICHD) Global Net-
work for Women’s and Children’s Health Research (GN)
Maternal and Neonatal Health Registry (MNHR) is a five-
year, multi-country, population-based, prospectively col-
lected record of pregnancy outcomes including maternal
death. This data set is ideal to study a variety of medical
and social risk factors that might contribute to maternal
mortality. The goals of this paper are to describe maternal
mortality rates by site within the GN from 2010 to 2013
and to determine maternal, pregnancy-related, delivery
and postpartum characteristics that are associated with
maternal mortality.
Methods
We collected information from the MNHR for pregnan-
cies between January 1, 2010 and December 31, 2013. The
registry included research sites in the counties of Busia,
Bungoma and Kakamega (within the western region),
Kenya; Kafue and Chongwe (located south and east of the
capital city of Lusaka), Zambia; Belgaum and Bagalkot
(within the northern part of the southern state of Karna-
taka), India; Nagpur (within the state of Mahrashtra),
India; Thatta (two of the five sub-districts in the southern
Sindh province, near the city of Karachi), Pakistan;
Corrientes and Santiago del Estero, Argentina; and Chi-
maltenango (in the Western Highlands), Guatemala. The
sites represent urban and rural environments across a
range of human development indices (a composite score
statistic of life expectancy, education and income) from
0.465-0.828.
Data were collected from women who resided within
study clusters through a combination of methods, includ-
ing abstraction of medical records and by a series of
interviews conducted by trained study staff. Maternal
characteristics, including demographic information were
collected at the time a pregnant woman was screened
and consented. Although the goal was to identify women
as early as possible in pregnancy, women could be
enrolled at any point during pregnancy or after delivery.
Antenatal and delivery characteristics were recorded
within 3-7 days after delivery. Postpartum characteristics
were collected at a clinic or home visit at 6 weeks after
delivery. This information was collected regardless of
maternal or infant status at 6 weeks after delivery. We
excluded women who were lost to follow-up prior to
delivery and those who did not have records indicating
maternal status at the 6-week follow-up visit. Pregnancy
outcomes, including stillbirths and neonatal characteris-
tics, have been previously published and are therefore
not included in this paper [13].
We defined maternal death as the death of a woman
while pregnant or within 42 days of the end of pregnancy,
in accordance with the World Health Organization
(WHO). We defined fetal malposition as transverse lie,
oblique lie or breech. For maternal, antenatal, delivery
and post-partum characteristics, we reported the percent
of births resulting in a maternal death, using all recorded
pregnancies as the denominator irrespective of the deliv-
ery outcome (miscarriage, stillbirth, live birth, etc). We
also used the standard maternal mortality ratio
(MMR=maternal deaths/100,000 live births) to record
maternal death by site over time. The 95% confidence
interval for the maternal mortality ratio was approxi-
mated using the variance of the proportion of maternal
deaths for each site and year.
Generalized linear models were used to evaluate the
relationship of potential medical and social factors and
maternal mortality and to develop point and interval
estimates of relative risk associated with these factors.
Generalized estimating equations were used to account
for the correlation of outcomes within cluster to develop
appropriate confidence intervals. We ran a multivariable
regression model to determine the maternal, pregnancy-
related, delivery and postpartum factors that were asso-
ciated with maternal death. We included all medical and
social variables that could be associated with maternal
mortality and were reliably collected in the MNHR. We
included variables that were present at enrollment or
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around the time of delivery, including: maternal age,
maternal education, parity, antenatal care, birth atten-
dant, delivery mode, obstructed labor, fetal malposition,
hemorrhage and hypertensive disorders. We excluded
factors with significant missing fields. For the purposes
of the multivariable model, we defined the variable
hemorrhage as an antepartum or postpartum hemor-
rhage, and the variable hypertensive disorder as an ante-
partum hypertensive disorder or postpartum seizure or
convulsion. The model was further adjusted for clinical
site. Data are presented as adjusted risk ratios and 95%
confidence intervals. All analyses were performed at the
Data Coordinating Center at RTI International (Dur-
ham, NC) using SAS, Inc. (Version 9.3).
At each site, institutional review boards or research
ethics committees and ministries of health approved the
collection of data included in the MNHR. We used sensiti-
zation meetings to achieve approval within local commu-
nities prior to the initiation of the study, with informed
consent from individual participants. A data monitoring
committee, appointed by the NICHD oversees and reviews
the MNHR annually.
Results
During the study period, we recorded 277,736 deliveries,
262,887 live births and 402 maternal deaths (145 mater-
nal deaths/100,000 deliveries). This resulted in a MMR of
153/100,000 live births. We calculated maternal mortality
ratios by site (Table 1). MMR ranged from 72 in Argen-
tina to 321 in Pakistan. The MMR in Latin American
sites (91) was lower than the MMR in Asian (178) and
African sites (125). We observed an overall decrease in
the total MMR over a four-year period from 166 in 2010
to 126 in 2013. Sites that had reductions in the MMR in
the four-year period included: Kenya (133 to 98), Zambia
(158 to 76), Belgaum, India (169 to 87), Nagpur, India
(132 to 123), and Guatemala (157 to 68). Pakistan had
the highest MMR each year compared to the other sites
and the MMR increased from 2010 to 2013 (227 to 348).
Cumulative maternal mortality is illustrated in Figure 1.
Mothers who were >35 years old, had no formal educa-
tion or primary education only, had >2 children, or had a
previous pregnancy loss were more likely to die, (Table 2).
Antenatal and delivery characteristics that were associated
with increased risk of death included: inadequate antenatal
care, operative or assisted vaginal deliveries, obstructed
labor, fetal malposition, antepartum hemorrhage, hyper-
tensive disorders, and the receipt of many maternal medi-
cal treatments (e.g: blood transfusions, anticonvulsant
medications, intravenous fluids), (Table 3). Postpartum
characteristics that were associated with maternal death
included seizures or convulsions, hemorrhage, anemia,
hospitalization and the receipt of medical treatment,
(Table 4).
We evaluated the association between selected factors
that were associated with the death of the mother,
(Table 5). We excluded the factor of a previous living
child due to missing data or primiparous mothers
(n=94,393). We excluded the variable of delivery loca-
tion due to significant confounding with birth attendant.
When adjusted for study site and the other variables, no
formal education (RR 3.2 [1.5, 6.9]), primary education
Table 1. Maternal mortality ratio (MMR) by site and year
Region Africa Asia Latin America Total
Site Kenya Zambia Belgaum, India Nagpur, India Pakistan Argentina Guatemala
Births, n 35,603 27,614 84,573 41,293 49,602 9,860 29,191 277,736
Maternal deaths, n 44 34 99 44 146 7 28 402
Deliveries, n 36,060 27,863 85,160 41,574 50,191 9,921 29,392 280,161
Live births, n 35,300 26,997 78,189 38,326 45,439 9,781 28,855 262,887
Total MMR 124.6 125.9 126.6 114.8 321.3 71.6 97.0 152.9
MMR, (95% CI) ‡
2010 133.3
(56.9, 209.7)
157.8
(63.9, 251.7)
169.2
(112.1, 226.4)
132.1
(59.8, 204.3)
226.6
(146.2, 306.9)
106.6
(0.0, 228.1)
156.5
(47.6, 265.5)
165.9
(135.0, 196.8)
2011 127.1
(54.5, 199.7)
130.1
(44.5, 215.6)
124.0
(75.2, 172.9)
128.1
(55.4, 200.8)
354.7
(251.3, 458.1)
99.2
(0.0, 212.3)
61.1
(0.8, 121.4)
162.2
(131.8, 192.6)
2012 138.1
(59.2, 217.1)
137.4
(47.1, 227.6)
120.6
(73.0, 168.1)
74.9
(19.1, 130.6)
382.9
(263.3, 502.5)
0.0
(0.0, 0.0)
131.3
(45.1, 217.5)
155.5
(125.1, 185.9)
2013 98.0
(35.6, 160.3)
76.3
(13.0, 139.6)
87.2
(49.2, 125.1)
122.9
(53.5, 192.3)
347.7
(270.0, 425.5)
* 67.7
(0.0, 169.6)
125.5
(99.9, 151.2)
Total 124.6
(87.4, 161.9)
125.9
(83.3, 168.6)
126.6
(101.5, 151.7)
114.8
(80.7, 148.9)
321.3
(268.8, 373.8)
71.6
(18.3,124.9)
97.0
(60.9, 133.2)
152.9
(137.9, 168.0)
* Complete data are not available for Argentina for year 2013
‡ The 95% confidence interval for the MMR approximated using the variance of the proportion of maternal deaths for each site and year.
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only (RR 3.4 [1.6, 7.5]), secondary education only (RR 2.5
[1.1, 5.7]), lack of antenatal care (RR 1.8 [1.2, 2.5]), cae-
sarean section delivery (RR 1.9 [1.3, 2.8]), hemorrhage
(RR 3.3 [2.2, 5.1]), and hypertensive disorders (RR 7.4
[5.2, 10.4]) were associated with a higher risk of death.
Using the variables that were found to be significant in
the model, we evaluated social factors and measures of
care that might influence MMR by year (Figure 2) and
Figure 1 Cumulative maternal mortality ratio by site and years* Individual site data for Argentina excluded due to incomplete data for year
2013. Data from Argentina are included in the overall total. * MNHR 2010-2013 deliveries excluding women lost to follow-up prior to delivery or
missing maternal status at 6 weeks after delivery.
Table 2. Maternal characteristics by maternal status at 6 weeks
Characteristic n(%)* RR of maternal death versus alive at six weeks
(95% CI) ‡
Women who
died
n=402
Women alive six weeks after
delivery
n=277,334
Total
n=277,736
Maternal age
< 20 36 (9.0) 32,987 (11.9) 33,023
(11.9)
0.8 (0.6, 1.1)
20-35 332 (83.4) 233,322 (84.3) 233,654
(84.3)
1.0
> 35 30 (7.5) 10,594 (3.8) 10,624 (3.8) 2.0 (1.3, 3.0)
Maternal education
No formal education 164 (41.1) 69,204 (25.1) 69,368
(25.1)
4.2 (2.2, 8.0)
Primary 132 (33.1) 103,663 (37.5) 103,795
(37.5)
2.3 (1.2, 4.6)
Secondary 92 (23.1) 83,276 (30.2) 83,368
(30.2)
2.0 (1.0, 4.0)
University + 11 (2.8) 19,953 (7.2) 19,964 (7.2) 1.0
Parity
0 131 (32.7) 93,337 (33.8) 93,468
(33.8)
1.3 (1.0, 1.6)
1-2 131 (32.7) 117,115 (42.4) 117,246
(42.3)
1.0
> 2 139 (34.7) 66,071 (23.9) 66,210
(23.9)
1.8 (1.4, 2.2)
Last pregnancy did not result in a
live birth
34 (12.6) 11,132 (6.1) 11,166 (6.1) 2.1 (1.5, 3.1)
* The denominator used to determine the percentage of women with each characteristic varies due to missing data.
‡ Generalized linear models were used to evaluate the relationship of potential factors and maternal mortality and to develop point and interval estimates of
relative risk associated with these factors. Generalized estimating equations were used to account for the correlation of outcomes within cluster to develop
appropriate confidence intervals. Unless otherwise noted, the reference group is women who did not have the listed characteristic.
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Table 3. Antenatal and delivery characteristics by maternal status at 6 weeks
Characteristic n(%)* RR of maternal death versus alive at six weeks
(95% CI) ‡
Women who
died
n=402
Women alive six weeks after
delivery
n=277,334
Total
n=277,736
No antenatal care 29 (7.4) 10,640 (3.8) 10,669 (3.9) 1.7 (1.2, 2.5)
Fewer than 4 antenatal care
visits
94 (59.1) 72,527 (48.4) 72,621
(48.4)
1.5 (1.1, 2.2)
Birth attendant
Physician 148 (46.8) 106,671 (38.5) 106,819
(38.5)
1.0
Nurse/midwife/health worker 69 (21.8) 88,243 (31.8) 88,312
(31.8)
0.5 (0.4, 0.7)
Traditional birth attendant 66 (20.9) 63,817 (23.0) 63,883
(23.0)
0.6 (0.4, 0.8)
Family/other 33 (10.4) 18,558 (6.7) 18,591 (6.7) 1.1 (0.8, 1.7)
Delivery location
Hospital 169 (53.3) 126,426 (45.6) 126,595
(45.6)
1.0
Clinic 52 (16.4) 68,629 (24.8) 68,681
(24.7)
0.5 (0.4, 0.7)
Home/other 96 (30.3) 82,197 (29.6) 82,293
(29.6)
0.7 (0.6, 1.0)
Delivery mode
Vaginal 222 (71.4) 230,853 (86.1) 231,075
(86.1)
1.0
Vaginal assisted 15 (4.8) 4,145 (1.5) 4,160 (1.6) 3.4 (1.8, 6.6)
Caesarean section 74 (23.8) 32,973 (12.3) 33,047
(12.3)
2.4 (1.8, 3.2)
Obstructed labor 79 (20.4) 29,735 (10.7) 29,814
(10.8)
2.0 (1.6, 2.6)
Fetal Malposition 27 (7.1) 5,879 (2.1) 5,906 (2.1) 3.4 (2.3, 5.0)
Antepartum hemorrhage 46 (11.9) 6,089 (2.2) 6,135 (2.2) 5.7 (3.7, 8.8)
Hypertensive disorders 78 (20.5) 8,039 (2.9) 8,117 (2.9) 8.4 (6.3, 11.2)
Maternal treatment provided
Antibiotics 173 (52.9) 103,941 (37.7) 104,114
(37.8)
2.1 (1.7, 2.7)
Corticosteroids 12 (9.4) 6,060 (5.3) 6,072 (5.3) 1.8 (0.9, 3.5)
Oxytocics (including
misoprostol)
140 (43.3) 108,524 (39.5) 108,664
(39.5)
1.2 (1.0, 1.6)
Blood transfusion 92 (28.3) 3,889 (1.4) 3,981 (1.4) 26.6 (19.7, 36.0)
Removal of retained products 42 (12.9) 15,799 (5.7) 15,841 (5.7) 2.7 (1.7, 4.3)
Anticonvulsants 31 (9.7) 3,288 (1.2) 3,319 (1.2) 8.9 (5.6, 14.0)
IV Fluids 188 (57.5) 93,590 (33.9) 93,778
(34.0)
2.9 (2.2, 3.7)
Forceps/vacuum 13 (4.0) 1,913 (0.7) 1,926 (0.7) 5.6 (3.1, 10.0)
Other surgery/treatment 24 (7.4) 10,891 (4.0) 10,915 (4.0) 2.1 (1.3, 3.3)
* The denominator used to determine the percentage of women with each characteristic varies due to missing data.
‡ Generalized linear models were used to evaluate the relationship of potential factors and maternal mortality and to develop point and interval estimates of
relative risk associated with these factors. Generalized estimating equations were used to account for the correlation of outcomes within cluster to develop
appropriate confidence intervals. Unless otherwise noted, the reference group is women who did not have the listed characteristic.
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pregnancy complications that might influence MMR by
year (Figure 3).
Discussion
Sites in our population-based multi-national registry had
a combined MMR of 153, a number which is higher
than the WHO global target for 2030 of less than 70
maternal deaths per 100,000 live births and higher than
the supplementary goal that no country should have an
MMR greater than 140 [14]. This observation highlights
the continued challenge of maternal mortality and the
need to improve the health and medical care of preg-
nant women in some areas. We recorded considerable
variation in the MMR by site with a range of 72 in
Argentina to 321 in Pakistan. Although, we did not
observe a consistent yearly decline in MMR in each site
Table 4. Postpartum maternal characteristics by maternal status at 6 weeks
Characteristic n(%)* RR of maternal death versus alive at six weeks (95%
CI) ‡
Women who
died
n=402
Women alive six weeks after
delivery
n=277,334
Total
n=277,736
Seizures/convulsions 32 (23.9) 227 (0.1) 259 (0.1) 325.3 (212.4, 498.0)
Hemorrhage 27 (20.5) 1,491 (0.5) 1,518 (0.6) 45.3 (25.6, 80.1)
Anemia 48 (36.1) 5,304 (1.9) 5,352 (1.9) 28.5 (17.4, 46.8)
Hospitalized 53 (35.6) 750 (0.3) 803 (0.3) 185.7 (125.5, 274.8)
Received medical
treatment
88 (59.1) 9,803 (3.6) 9,891 (3.6) 38.1 (24.6, 59.0)
* The denominator used to determine the percentage of women with each characteristic varies due to missing data.
‡ Generalized linear models were used to evaluate the relationship of potential factors and maternal mortality and to develop point and interval estimates of
relative risk associated with these factors. Generalized estimating equations were used to account for the correlation of outcomes within cluster to develop
appropriate confidence intervals. Unless otherwise noted, the reference group is women who did not have the listed characteristic.
Table 5. Multivariable model with outcome of maternal death by 6 weeks after delivery*
Model Covariates Adjusted Relative Risk
Maternal age
Maternal age: <20 vs. 20-35 1.1 (0.7, 1.6)
Maternal age: >35 vs. 20-35 1.2 (0.6, 2.4)
Maternal education
Maternal education: no formal vs university 3.2 (1.5, 6.9)
Maternal education: primary vs university 3.4 (1.6, 7.5)
Maternal education: secondary vs university 2.5 (1.1, 5.7)
Parity
Parity:0 vs. 1-2 1.3 (1.0, 1.7)
Parity:>2 vs. 1-2 1.4 (1.0, 2.0)
No antenatal care vs. at least 1 antenatal care visit 1.8 (1.2, 2.5)
Birth attendant
Birth attendant: nurse/midwife/health worker vs physician 0.4 (0.3, 0.6)
Birth attendant: traditional birth attendant vs physician 0.6 (0.3, 1.0)
Birth attendant: family/other vs physician 0.4 (0.2, 0.7)
Delivery mode
Delivery mode: vaginal-assisted vs vaginal 1.8 (0.9, 3.7)
Delivery mode: caesarean-section vs vaginal 1.9 (1.3, 2.8)
Obstructed labor: yes vs no 1.1 (0.8, 1.5)
Fetal Malposition: yes vs no 1.3 (0.8, 2.0)
Hemorrhage: yes vs. no 3.3 (2.2, 5.1)
Hypertensive disorders including seizures / convulsions: yes vs. no 7.4 (5.2, 10.4)
* MNHR 2010-2013 deliveries excluding women lost to follow-up prior to delivery or missing maternal status at 6 weeks after delivery. Multivariable model
adjusted for clinical site.
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every year, our overall MMR for all sites did improve,
except for Pakistan. Pakistan was an outlier with the
highest MMR compared to all other sites each year with
no improvement over 4 years. The potential reasons for
the high MMR in the Pakistan site are addressed else-
where [15].
We performed exploratory analyses to investigate the
association with positive and negative factors that might
have contributed to the overall decline in MMR. We
observed an increase in the percentage of deliveries that
were attended by a physician and delivery by caesarean
section, but it is not clear that the change in either of
these factors alone explains the decline in MMR. We did
not observe a decrease in complications of pregnancy
(fetal malposition, obstructed labor, hemorrhage or
hypertensive disorders) that might have explained the
lower MMR. In fact, some of these underlying risk factors
increased over time. Taken together, these observations
might indicate that improvements in measures of care,
without a decline in underlying disease prevalence
Figure 2 Social factors and measures of care, by year* MNHR 2010-2013 deliveries excluding women lost to follow-up prior to delivery or
missing maternal status at 6 weeks after delivery.
Figure 3 Pregnancy complications, by year* MNHR 2010-2013 deliveries excluding women lost to follow-up prior to delivery or missing
maternal status at 6 weeks after delivery.
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improve maternal mortality rates. Another possibility is
our study sites include participants potentially enrolled in
various research studies to improve maternal and new-
born health. Although we did not observe a consistent
improvement in maternal mortality in each site every
year, it is possible that participation in our research stu-
dies has decreased overall maternal mortality.
We identified important modifiable factors associated
with maternal death. Consistent with previously pub-
lished works, we identified hemorrhage and hypertensive
disorders as treatable factors that are the most highly
associated with maternal death [16-18]. We also identi-
fied an increased risk of death among women whose
deliveries were attended by a physician and those who
had a caesarean section. These associations may result
from confounding by the indication for the operative
delivery, however the indications for these deliveries were
not collected in this dataset. We presume that women
are delivered by caesarean section in response to a condi-
tion that places them in a higher risk category for mortal-
ity; therefore these women have a higher baseline risk of
mortality. This presumption is supported by previous
publications that report that the largest proportion of
maternal deaths take place in health care facilities where
underlying conditions that often result in mortality are
more likely to be treated [15].
The MNHR has many strengths for analyses of factors
for maternal death. We have a large data set of pregnan-
cies and delivery outcomes in low and middle-income
countries that has been prospectively collected and vali-
dated. Most multi-country data from low and middle-
income countries are not of such high-quality and many
rely on model-based estimates for maternal mortality. We
include all pregnant women who reside within study com-
munity, therefore providing population-level data for each
region represented. We enroll women who deliver in facil-
ities and outside of facilities and do not rely on the health
systems in order to identify eligible women, therefore
representing a cross-sectional cohort of residents within
these regions. We have an extremely high follow-up rate,
which permits complete data to 6 weeks post-partum.
Despite our robust, prospective data set, our study
design limits generalizability to other low- and middle-
income countries. Although we were able to capture
nearly all of the pregnancies within the study commu-
nities, our communities might not reflect delivery out-
comes in diverse regions within each country. Our study
sites generally cover one district or province that might
have different birth outcomes compared to other regions
within the country, limiting our ability to draw inferences
about mortality within each country as a whole. Although
our goal is to identify women early in pregnancy, sites
varied in their ability to identify pregnancies early, there-
fore it is possible that we have under-reported maternal
deaths occurring early in pregnancy or those related to
medical termination of pregnancy or miscarriage, as
these pregnancies represented only 3.4% of our sample.
Although robust, our dataset does not record all factors
that might be associated with maternal mortality, such
as: maternal nutritional status, timing of referral, or
access to medical care. Our data collection techniques
limited our ability to assign an accurate cause of death.
For example, we collected data on the presence of sepsis
around the time of delivery, but there was significant
variability in reporting by site, therefore we have
excluded this variable from our report. Our team has
developed a cause of death algorithm to address this pro-
blem and will be testing this tool in the future [19].
The MNHR can be used to identify preventable causes
of maternal mortality in diverse settings. The MNHR
has utility in informing public health strategies that can
be monitored over time to determine their impact on
reducing maternal mortality. Systematic data collection
strategies that include all births in a region are essential
to understanding the underlying causes of maternal
mortality and should guide the development of compre-
hensive intervention strategies to reduce maternal
mortality.
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